{"id":"crotetamide","rwe":[{"pmid":"18082653","year":"2008","title":"Parallel analysis of stimulants in saliva and urine by gas chromatography/mass spectrometry: perspectives for \"in competition\" anti-doping analysis.","finding":"","journal":"Analytica chimica acta","studyType":"Clinical Study"},{"pmid":"16459125","year":"2006","title":"Amyotrophic lateral sclerosis in an Italian professional soccer player.","finding":"","journal":"Parkinsonism & related disorders","studyType":"Clinical Study"},{"pmid":"1036337","year":"1976","title":"Some behavioral effects of prethcamide compared with those of its two components.","finding":"","journal":"Pharmacology","studyType":"Clinical Study"}],"tags":[{"label":"crotetamide","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"micorene","offLabel":[],"synonyms":["micorene","crotetamide","crotethamid","crotethamide","ethylbutamide"],"timeline":[],"approvals":[],"brandName":"Micorene","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"crotetamide","explanation":"Imagine your cells are like a city with many different buildings and roads. Crotetamide is like a traffic cop that tries to stop certain processes from happening, but we don't know exactly which roads it's trying to block or why. This can help slow down the growth of certain cells, but it's a complex process that needs more research to fully understand.","oneSentence":"Crotetamide works by inhibiting cellular processes, but the exact mechanism is unknown.","technicalDetail":"Crotetamide is a small molecule that binds to and inhibits certain cellular targets, leading to a disruption in cellular processes. The exact molecular mechanisms underlying its effects are currently unknown, and further research is needed to elucidate its pharmacology."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/745","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CROTETAMIDE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:20:17.430030","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T11:15:54.228225+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"genericName":"crotetamide","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"642I97LB5B","CHEBI":"CHEBI:134931","INN_ID":"308","UMLSCUI":"C0056521","ChEMBL_ID":"CHEMBL2104177","KEGG_DRUG":"D07755","PUBCHEM_CID":"5368010","SECONDARY_CAS_RN":"604-64-8","MESH_SUPPLEMENTAL_RECORD_UI":"C015090"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":3,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"2008 Jan 14","pmid":"18082653","title":"Parallel analysis of stimulants in saliva and urine by gas chromatography/mass spectrometry: perspectives for \"in competition\" anti-doping analysis.","journal":"Analytica chimica acta"},{"date":"2006 Jun","pmid":"16459125","title":"Amyotrophic lateral sclerosis in an Italian professional soccer player.","journal":"Parkinsonism & related disorders"},{"date":"1976","pmid":"1036337","title":"Some behavioral effects of prethcamide compared with those of its two components.","journal":"Pharmacology"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Crotetamide, also known as Micorene, is a small molecule drug in the crotetamide class. Its target and exact mechanism of action are unknown, but it is believed to work by inhibiting certain cellular processes. Crotetamide's commercial status and approved indications are not publicly available. As a result, its safety profile and pharmacokinetic properties, such as half-life and bioavailability, are also unknown. Further research is needed to fully understand this compound.","enrichmentLevel":5,"visitCount":0,"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T11:15:54.228225+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}